RKDA SEC Filings: 8-K, 10-Q, S-3 & 424B

Financials

TYPE

HEADLINE

FILED AT

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Aug 13, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

May 14, 2026

10-K/A

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]

Apr 30, 2026

10-K

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Mar 26, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Nov 7, 2025

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Aug 14, 2025

News

TYPE

HEADLINE

FILED AT

8-K

Arcadia Biosciences Announces Voting Results from 2026 Annual Meeting of Stockholders

Sep 15, 2026

8-K

Arcadia Biosciences Receives Nasdaq Deficiency Notice Regarding Stockholders’ Equity

Sep 4, 2026

8-K

Arcadia Biosciences Reports Q2 2026 Financial Results and Business Updates

Aug 13, 2026

8-K

Arcadia Biosciences Receives Nasdaq Deficiency Notice Regarding Minimum Bid Price

Aug 7, 2026

8-K

Arcadia Biosciences Announces 2025 Executive Compensation Update and 2026 Annual Meeting Date

Jul 2, 2026

8-K

Arcadia Biosciences Announces $4 Million Private Placement

Jun 15, 2026

Prospectus

TYPE

HEADLINE

FILED AT

424B3

SHARE RESALE REGISTRATION | Shares: 11,922,333

Jul 8, 2026

424B3

SHARE RESALE REGISTRATION | Shares: 1,673,792 | Bank: H.C. Wainwright & Co., LLC

Feb 10, 2026

425

Form 425 - Prospectuses and communications, business combinations

Dec 29, 2025

425

Form 425 - Prospectuses and communications, business combinations

Aug 14, 2025

425

Form 425 - Prospectuses and communications, business combinations

May 8, 2025

425

Form 425 - Prospectuses and communications, business combinations

May 2, 2025

Registrations

TYPE

HEADLINE

FILED AT

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Sep 30, 2026

Form D - Notice of Exempt Offering of Securities - Item 06b

Jun 26, 2026

S-3

SHARE RESALE REGISTRATION

Jun 26, 2026

S-3

SHARE RESALE REGISTRATION

Jan 27, 2026

Form D - Notice of Exempt Offering of Securities - Item 06b

Jan 26, 2026

Form RW - Registration Withdrawal Request

Jan 16, 2026

Proxies

TYPE

HEADLINE

FILED AT

Ownerships

TYPE

HEADLINE

FILED AT

SCHEDULE 13G

MJL Manager LLC (Filed by)

Sep 30, 2026

Yoder Amy (Reporting)

Sep 14, 2026

Comcowich Kevin (Reporting)

Sep 14, 2026

WALLER GREGORY D (Reporting)

Sep 14, 2026

Murray Lilian Shackelford (Reporting)

Sep 14, 2026

SCHEDULE 13G/A

ARMISTICE CAPITAL, LLC (Filed by)

Aug 14, 2026

Other

TYPE

HEADLINE

FILED AT

EFFECT

Form EFFECT - Notice of Effectiveness

Jul 9, 2026

EFFECT

Form EFFECT - Notice of Effectiveness

Feb 11, 2026

CORRESP

Form CORRESP - Correspondence

Feb 5, 2026

LETTER

Form UPLOAD - SEC-generated letter

Feb 5, 2026

CORRESP

Form CORRESP - Correspondence

Jan 27, 2026

EFFECT

Form EFFECT - Notice of Effectiveness

Apr 18, 2023

TYPE

HEADLINE

FILED AT

TYPE

HEADLINE

FILED AT

TYPE

HEADLINE

FILED AT

TYPE

HEADLINE

FILED AT

Financials

TYPE

HEADLINE

FILED AT

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Aug 13, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

May 14, 2026

10-K/A

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]

Apr 30, 2026

10-K

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Mar 26, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Nov 7, 2025

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Aug 14, 2025

News

TYPE

HEADLINE

FILED AT

8-K

Arcadia Biosciences Announces Voting Results from 2026 Annual Meeting of Stockholders

Sep 15, 2026

8-K

Arcadia Biosciences Receives Nasdaq Deficiency Notice Regarding Stockholders’ Equity

Sep 4, 2026

8-K

Arcadia Biosciences Reports Q2 2026 Financial Results and Business Updates

Aug 13, 2026

8-K

Arcadia Biosciences Receives Nasdaq Deficiency Notice Regarding Minimum Bid Price

Aug 7, 2026

8-K

Arcadia Biosciences Announces 2025 Executive Compensation Update and 2026 Annual Meeting Date

Jul 2, 2026

8-K

Arcadia Biosciences Announces $4 Million Private Placement

Jun 15, 2026

Prospectus

TYPE

HEADLINE

FILED AT

424B3

SHARE RESALE REGISTRATION | Shares: 11,922,333

Jul 8, 2026

424B3

SHARE RESALE REGISTRATION | Shares: 1,673,792 | Bank: H.C. Wainwright & Co., LLC

Feb 10, 2026

425

Form 425 - Prospectuses and communications, business combinations

Dec 29, 2025

425

Form 425 - Prospectuses and communications, business combinations

Aug 14, 2025

425

Form 425 - Prospectuses and communications, business combinations

May 8, 2025

425

Form 425 - Prospectuses and communications, business combinations

May 2, 2025

Registrations

TYPE

HEADLINE

FILED AT

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Sep 30, 2026

Form D - Notice of Exempt Offering of Securities - Item 06b

Jun 26, 2026

S-3

SHARE RESALE REGISTRATION

Jun 26, 2026

S-3

SHARE RESALE REGISTRATION

Jan 27, 2026

Form D - Notice of Exempt Offering of Securities - Item 06b

Jan 26, 2026

Form RW - Registration Withdrawal Request

Jan 16, 2026

Proxies

TYPE

HEADLINE

FILED AT

Ownerships

TYPE

HEADLINE

FILED AT

SCHEDULE 13G

MJL Manager LLC (Filed by)

Sep 30, 2026

Yoder Amy (Reporting)

Sep 14, 2026

Comcowich Kevin (Reporting)

Sep 14, 2026

WALLER GREGORY D (Reporting)

Sep 14, 2026

Murray Lilian Shackelford (Reporting)

Sep 14, 2026

SCHEDULE 13G/A

ARMISTICE CAPITAL, LLC (Filed by)

Aug 14, 2026

Other

TYPE

HEADLINE

FILED AT

EFFECT

Form EFFECT - Notice of Effectiveness

Jul 9, 2026

EFFECT

Form EFFECT - Notice of Effectiveness

Feb 11, 2026

CORRESP

Form CORRESP - Correspondence

Feb 5, 2026

LETTER

Form UPLOAD - SEC-generated letter

Feb 5, 2026

CORRESP

Form CORRESP - Correspondence

Jan 27, 2026

EFFECT

Form EFFECT - Notice of Effectiveness

Apr 18, 2023

Arcadia Biosciences, Inc. RKDA · SEC Filings